Megamet PG 2mg/500mg/15mg Tablet SR

Overview Megamet PG 2mg/500mg/15mg Tablet SR

Metformin-Glimepiride-Pioglitazone extended-release tablets (2mg/500mg/15mg) are a triple-combination medication managing blood glucose. This medication, used alongside diet and exercise, enhances glycemic control in adults with type 2 diabetes. It facilitates improved insulin utilization, consequently reducing blood sugar. Dosage and duration for Metformin-Glimepiride-Pioglitazone extended-release tablets should strictly adhere to your physician's instructions. Administer this medication with food to minimize gastrointestinal distress. For missed doses, take it immediately unless the next dose is imminent; in that case, omit the missed dose and resume the usual schedule. Never double the dose. Overdosage can result in hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol consumption, or meal skipping may precipitate hypoglycemia. Regular blood glucose monitoring is essential during treatment. Common adverse reactions include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to commencing treatment, disclose any kidney, liver, or heart conditions to your doctor. Pregnant or lactating individuals should consult their physician before use. Kidney function tests will be conducted before treatment initiation. Limit alcohol consumption as it may exacerbate side effects.

Primary Ingredients of Megamet PG 2mg/500mg/15mg Tablet SR

No information provided. Please provide the text you wish to be rewritten.

Uses of Megamet PG 2mg/500mg/15mg Tablet SR

Managing type 2 diabetes

Major Benefits of Megamet PG 2mg/500mg/15mg Tablet SR:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and treatment schedule. Ingest the entire tablet whole; avoid chewing, crushing, or fracturing it. Consume Megamet PG 2mg/500mg/15mg Extended-Release Tablets with a meal.

Common Side effects of Megamet PG 2mg/500mg/15mg Tablet SR:

• Hypoglycemia (low blood glucose level)
• Headache
• Nausea
• Diarrhea
• Dizziness
• Vomiting
• Anemia (low number of red blood cells)
• Weakness
• Sinus infection

How to use Megamet PG 2mg/500mg/15mg Tablet SR:

Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the entire tablet without chewing, crushing, or fracturing it. Consume the Megamet PG 2mg/500mg/15mg Extended-Release tablet with food.

How Megamet PG 2mg/500mg/15mg Tablet SR works:

Megamet PG SR tablets (2mg/500mg/15mg) combine glimepiride, metformin, and pioglitazone—three antidiabetic agents with complementary actions. This triple therapy effectively manages blood glucose levels when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin release to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and enhancing insulin sensitivity. Pioglitazone, a thiazolidinedione, further improves insulin responsiveness.

What if you forget to take Megamet PG 2mg/500mg/15mg Tablet SR :

Should you forget a Megamet PG 2mg/500mg/15mg Tablet SR dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.